CollPlant Biotechnologies (CLGN) Cash from Financing Activities (2018 - 2026)

CollPlant Biotechnologies has reported Cash from Financing Activities for 8 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (changed N/A YoY), and the FY2025 full-year result was $3.1 million, up 34366.67% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $1.7 million, up from $9000.0 in the prior quarter.
• The five-year high for Cash from Financing Activities was $1.7 million in Q1 2026, with the low at $9000.0 in Q1 2024.
• Historically, Cash from Financing Activities has averaged $672857.1 across 4 years, with a median of $400000.0 in 2022.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 181.69% — and 2024, when it sank 98.88%.
• CollPlant Biotechnologies' Cash from Financing Activities stood at $400000.0 in 2022, then sank by 46.0% to $216000.0 in 2023, then tumbled by 95.83% to $9000.0 in 2024, then soared by 19000.0% to $1.7 million in 2026.
• The last three Cash from Financing Activities figures came in at $1.7 million (Q1 2026), $9000.0 (Q1 2024), and $216000.0 (Q3 2023), per Business Quant data.